Alerts will be sent to your verified email
Verify EmailCHECKPOINT
Rubra Medicaments
|
Samyak International
|
Regent Enterprises
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-2.03 % | 1.23 % | -0.22 % |
5yr average Equity Multiplier
|
1.44 | 1.43 | 1.83 |
5yr Average Asset Turnover Ratio
|
1.44 | 0.4 | 9.16 |
5yr Avg Net Profit Margin
|
-0.31 % | 1.7 % | -0.01 % |
Price to Book
|
35.84 | 0.36 | 0.5 |
P/E
|
223.95 | 0.0 | 11.97 |
5yr Avg Cash Conversion Cycle
|
183.71 Days | -79.6 Days | 14.86 Days |
Inventory Days
|
0.0 | 82.16 Days | 7.65 Days |
Days Receivable
|
183.71 Days | 68.76 Days | 26.27 Days |
Days Payable
|
33.56 Days | 214.47 Days | 15.97 Days |
5yr Average Interest Coverage Ratio
|
-248.31 | 2.64 | 0.2 |
5yr Avg ROCE
|
-2.28 % | 2.62 % | -0.21 % |
5yr Avg Operating Profit Margin
|
-0.3 % | 10.46 % | -0.17 % |
5 yr average Debt to Equity
|
0.06 | 0.17 | 0.0 |
5yr CAGR Net Profit
|
0.0 | n/a | n/a |
5yr Average Return on Assets
|
-1.63 % | 1.0 % | -0.02 % |
Shareholdings
|
|||
Promoter Holding
|
0.0 | 22.35 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 13.17 % | -1.12 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Rubra Medicaments
|
Samyak International
|
Regent Enterprises
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|